A phase II, multicenter, open-label study of [fam-] trastuzumab deruxtecan (DS 8201a) in subjects with HER2-expressing gastric cancer.

被引：1

作者：

Shitara, Kohei

Bang, Yung-Jue

Chung, Hyun Cheol

Yabusaki, Hiroshi

Iwasa, Satoru

Sakai, Daisuke

Muro, Kei

Sugimoto, Naotoshi

Yasui, Hisateru

Gamoh, Makio

Murakawa, Yasuko

Negoro, Yuji

Nishina, Tomohiro

Hosaka, Hisashi

Omuro, Yasushi

Kawaguchi, Yoshinori

Sugihara, Masahiro

Saito, Kaku

Dalal, Rita

Yamaguchi, Kensei

机构：

[1] Natl Canc Ctr Hosp East, Chiba, Japan

[2] Seoul Natl Univ Hosp, Seoul, South Korea

[3] Yonsei Canc Ctr, Seoul, South Korea

[4] Niigata Canc Ctr Hosp, Niigata, Japan

[5] Natl Canc Ctr, Dept Expt Therapeut, Tokyo, Japan

[6] Osaka Univ Hosp, Osaka, Japan

[7] Aichi Canc Ctr Hosp, Dept Clin Oncol, Nagoya, Aichi, Japan

[8] Osaka Int Canc Inst, Osaka, Japan

[9] Kobe City Med Ctr Gen Hosp, Kobe, Hyogo, Japan

[10] Osaki Citizen Hosp, Osaki, Japan

[11] Miyagi Canc Ctr, Natori, Miyagi, Japan

[12] Kochi Hlth Sci Ctr, Kochi, Japan

[13] Natl Hosp Org Shikoku Canc Ctr, Matsuyama, Ehime, Japan

[14] Gunma Prefectural Canc Ctr, Ota, Japan

[15] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Tokyo, Japan

[16] Daiichi Sankyo Co Ltd, Tokyo, Japan

[17] Daiichi Sankyo Inc, Basking Ridge, NJ USA

[18] Japanese Fdn Canc Res, Canc Inst Hosp, Tokyo, Japan

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 04期

关键词：

D O I：

10.1200/JCO.2019.37.4_suppl.TPS180

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

TPS180

引用

页数：2